Lead, Ocular Surface Marketing
Harrow
Summary
The accountable marketing owner for Harrow's Ocular Surface product portfolio (e.g., VEVYE, TYRVAYA, NATACYN, VERKAZIA, FLAREX, et al.) from brand strategy through field execution. Serves as the marketing counterpart to the Head, Sales—Ocular Surface, so brand, message, and field execution run as one franchise plan. Accountable for the growth and revenue performance of the Ocular Surface portfolio of prescription brands.
Job description
Position Summary
The accountable marketing owner for Harrow's Ocular Surface product portfolio (e.g., VEVYE, TYRVAYA, NATACYN, VERKAZIA, FLAREX, et al.) from brand strategy through field execution. Serves as the marketing counterpart to the Head, Sales—Ocular Surface, so brand, message, and field execution run as one franchise plan. Accountable for the growth and revenue performance of the Ocular Surface portfolio of prescription brands.
Core Responsibilities
- Own the Ocular Surface franchise strategy and annual brand plans; set priorities across the dry eye, specialty, and additional brands.
- Create demand with optometrists and ophthalmologists: targeting, segmentation, positioning, and messaging the field executes.
- Lead and develop brand managers; manage agencies and the franchise marketing budget.
- Translate pharmacy-benefit dynamics (formulary, prior authorization, Part D, copay) into pull-through programs with Market Access and Access & Patient Solutions Marketing.
- Build franchise congress plans (e.g., AAO, American Academy of Optometry, SECO, Vision Expo) and KOL programs with Professional Relations & KOL Development.
- Accountable for franchise demand forecasts and KPIs; report results with the Head, Sales—Ocular Surface.
- Lead annual brand planning and long-range strategic planning for the franchise.
- Lead qualitative and quantitative market research to deepen understanding of customers, brands, and the market.
- Serve as marketing liaison to field training, sales operations, reimbursement, and investor relations.
- Own franchise marketing budgets and accruals across HCP and patient programs.
- Serve as the subject-matter expert and brand ambassador for the Ocular Surface franchise, internally and externally.
- Partner with the Thought Leader/ProEd lead and stay in regular contact with thought leaders, influencers, and key stakeholder groups for insights and market intelligence, including spending time in the field with Sales to see how materials and messaging are delivered and received in market.
- Own the franchise omnichannel plan across personal and non-personal channels with Digital Marketing.
- Establish and lead a Field Input Team (FIT) to test materials and message effectiveness with the field.
Qualifications & Requirements
- Bachelor's degree; 10+ years in pharma or biotech marketing, including 5+ in brand leadership.
- 3+ years managing marketers.
- Launch experience with prescription brands.
- Experience marketing a pharmacy-benefit product, including access pull-through.
- Deep experience developing and leveraging the marketing tech stack.
- Experience leading a team through PRC/MLR review.
- Proficiency with AI platforms such as ChatGPT and Claude, and with Slack.
Preferred Qualifications
- Dry eye or ocular surface marketing experience, including the optometry channel.
- Field sales experience.
- Proficiency with Salesforce, Pardot/HubSpot/etc., Power BI, and Google Analytics; Adobe Suite a plus.
Requirements
- Bachelor's degree
- 10+ years in pharma or biotech marketing
- 5+ years in brand leadership
- 3+ years managing marketers
- Launch experience with prescription brands
- Experience marketing a pharmacy-benefit product, including access pull-through
- Deep experience developing and leveraging the marketing tech stack
- Experience leading a team through PRC/MLR review
- Proficiency with AI platforms such as ChatGPT and Claude, and with Slack
Benefits
- Remote (U.S.)
- Bonus
- Approximately 30% travel
Company overview
Harrow Health, Inc. (NASDAQ: HROW) is a publicly traded pharmaceutical company headquartered in Nashville, Tennessee, specializing in ophthalmic healthcare solutions. Founded in 2012 and formerly known as Imprimis Pharmaceuticals, the company has established itself as a growing leader in the ophthalmic pharmaceutical market. Harrow operates through multiple subsidiaries including ImprimisRx, its compounding pharmacy business that produces cGMP ophthalmic eye drops and sterile compounded products. The company's core mission focuses on providing affordable and accessible medications while maintaining an unyielding dedication to innovation. Harrow gained significant attention for developing low-cost alternatives to expensive medications, most notably creating a $1 per pill alternative to Daraprim during the Martin Shkreli controversy. The company's business model emphasizes developing inexpensive alternatives to off-patent medicines where single manufacturers charge excessive prices. With a portfolio that includes branded, generic, and compounded ophthalmic medications, Harrow serves healthcare providers and patients across the United States through its FDA-registered outsourcing facilities and nationwide distribution network.